Clinical Trial Update: Prostate Cancer Biomarker Enrichment and Treatment Selection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from the Canadian Cancer Trials Group focusing on biomarker-enriched patient selection and treatment decision in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING